Total Payments
$28,103
2024 Payments
$1,310
Companies
44
Transactions
442
Medicare Patients
3,523
Medicare Billing
$472,708
Payment Breakdown by Category
Other$12,400 (44.1%)
Food & Beverage$9,504 (33.8%)
Consulting$4,280 (15.2%)
Travel$1,911 (6.8%)
Education$7.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,700 | 3 | 34.5% |
| Food and Beverage | $9,504 | 424 | 33.8% |
| Consulting Fee | $4,280 | 4 | 15.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,700 | 1 | 9.6% |
| Travel and Lodging | $1,911 | 8 | 6.8% |
| Education | $7.50 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EKOS Corporation | $15,818 | 23 | $0 (2019) |
| GlaxoSmithKline, LLC. | $2,707 | 158 | $0 (2024) |
| Lilly USA, LLC | $2,400 | 1 | $0 (2021) |
| Eli Lilly and Company | $1,200 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,040 | 46 | $0 (2024) |
| Inari Medical, Inc. | $657.10 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $429.67 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $262.38 | 9 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $248.21 | 25 | $0 (2019) |
| United Therapeutics Corporation | $237.69 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,310 | 57 | Boehringer Ingelheim Pharmaceuticals, Inc. ($238.03) |
| 2023 | $1,211 | 39 | Inari Medical, Inc. ($288.55) |
| 2022 | $1,006 | 47 | GlaxoSmithKline, LLC. ($337.84) |
| 2021 | $4,468 | 49 | Lilly USA, LLC ($2,400) |
| 2020 | $619.04 | 35 | GlaxoSmithKline, LLC. ($262.98) |
| 2019 | $1,179 | 49 | GlaxoSmithKline, LLC. ($398.41) |
| 2018 | $14,186 | 96 | EKOS Corporation ($12,534) |
| 2017 | $4,124 | 70 | EKOS Corporation ($3,084) |
All Payment Transactions
442 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $41.46 | General |
| Category: Narcoplepsy | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: ANTIBIOTIC | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.78 | General |
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.17 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Pulmonology | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Immunology | ||||||
| 09/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $0.88 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $38.97 | General |
| Category: NEUROLOGY | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $105.21 | General |
| 08/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: RESPIRATORY | ||||||
| 07/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 866 | 1,281 | $244,306 | $114,766 |
| 2022 | 21 | 776 | 1,181 | $230,072 | $113,264 |
| 2021 | 21 | 897 | 1,322 | $243,932 | $119,987 |
| 2020 | 24 | 984 | 1,378 | $258,485 | $124,691 |
Total Patients
3,523
Total Services
5,162
Medicare Billing
$472,708
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 98 | 233 | $79,220 | $37,308 | 47.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 169 | 311 | $63,444 | $27,874 | 43.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 237 | $37,970 | $20,764 | 54.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 69 | 69 | $18,630 | $9,172 | 49.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 67 | 94 | $12,220 | $5,707 | 46.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 27 | $5,130 | $3,394 | 66.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $4,200 | $2,256 | 53.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $1,650 | $1,511 | 91.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 14 | $2,660 | $1,220 | 45.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 29 | 31 | $2,945 | $1,175 | 39.9% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 33 | 36 | $3,276 | $906.62 | 27.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 22 | 24 | $2,280 | $807.95 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $1,690 | $751.74 | 44.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $735.00 | $601.23 | 81.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 44 | 53 | $636.00 | $437.15 | 68.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 13 | 15 | $4,500 | $349.86 | 7.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 12 | 12 | $2,100 | $253.17 | 12.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 11 | 14 | $420.00 | $116.06 | 27.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 15 | 15 | $390.00 | $114.15 | 29.3% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 18 | 21 | $210.00 | $47.08 | 22.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 86 | 261 | $88,600 | $45,456 | 51.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 147 | 252 | $51,408 | $19,956 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 142 | $22,720 | $12,411 | 54.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 52 | 78 | $14,970 | $10,150 | 67.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 92 | $11,960 | $5,095 | 42.6% |
About Dr. Imad Shawa, MD
Dr. Imad Shawa, MD is a Critical Care Medicine healthcare provider based in Greenwood, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659341741.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Imad Shawa, MD has received a total of $28,103 in payments from pharmaceutical and medical device companies, with $1,310 received in 2024. These payments were reported across 442 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,700).
As a Medicare-enrolled provider, Shawa has provided services to 3,523 Medicare beneficiaries, totaling 5,162 services with total Medicare billing of $472,708. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Greenwood, IN
- Active Since 01/23/2006
- Last Updated 05/09/2023
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1659341741
Products in Payments
- EKOSONIC (Device) $15,818
- NUCALA (Biological) $1,438
- TRELEGY ELLIPTA (Drug) $973.54
- OFEV (Drug) $539.76
- TEZSPIRE (Biological) $396.45
- FLOWTRIEVER CATHETER, S (Device) $275.17
- GLASSIA (Biological) $217.75
- CT THROMBECTOMY SYSTEM KIT (Device) $196.63
- DUPIXENT (Biological) $190.97
- FlowTriever (Device) $185.30
- ELIQUIS (Drug) $182.00
- ANORO (Drug) $159.35
- Prolastin-C Liquid (Biological) $158.23
- Arikayce (Drug) $152.53
- IN.PACT Admiral (Device) $146.93
- REMODULIN (Drug) $119.41
- ORENITRAM (Drug) $118.28
- Solitaire (Device) $118.19
- SOLITAIRE X (Device) $118.16
- STIOLTO RESPIMAT (Drug) $108.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Greenwood
Dr. Sandeep Kukreja, M.d, M.D
Critical Care Medicine — Payments: $358,561
Critical Care Medicine $358,561
Dr. Faisal Khan, Md, MD
Critical Care Medicine — Payments: $169,121
Critical Care Medicine $169,121
Dr. Aaron Bruns, M.d, M.D
Critical Care Medicine — Payments: $4,727
Critical Care Medicine $4,727
Dr. Winston Nara, Md, MD
Critical Care Medicine — Payments: $3,963
Critical Care Medicine $3,963
Dr. Ruxandra Ionescu, Md, MD
Critical Care Medicine — Payments: $1,763
Critical Care Medicine $1,763
Melinda Quarles, Msn, Rn, MSN, RN
Critical Care Medicine — Payments: $368.07
Critical Care Medicine $368.07